Versius Plus

by CMR Surgical  · Based in United Kingdom → — Transforming Surgery. For Good.
General Surgery Obstetrics & Gynecology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Versius Plus is a next-generation robotic surgical platform developed and engineered for versatility and adaptability, driven by a digital ecosystem embedded at its core. It is designed to expand access to robotic surgery across all care settings due to its compact, modular design, allowing easy movement between departments and operating rooms without requiring a dedicated OR. Hospitals can seamlessly switch between robotic and non-robotic procedures in the same space.

The platform delivers precision and efficiency with a full surgical toolkit, including an integrated fluorescence visualization system, vLimeLite, for real-time ICG imaging. Its digitally driven ecosystem provides data-driven insights through two dedicated apps: Versius Connect for near-real-time procedural logbook for surgeons, and Versius Team for live dashboard tracking usage, case volume, and system efficiency. Versius Plus offers a full range of fully articulated standard instruments to enhance surgical precision and a powerful vision control with automatic brightness via a 26″, 3DHD screen.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Use Cases

  • Robotic-assisted cholecystectomy
  • Soft tissue minimal access surgery
  • Optimizing surgical program efficiency
  • Data-driven surgical performance analysis
  • Expanding access to robotic surgery in various care settings

What Physicians Need to Know

Surgical Planning Capabilities
Versius Plus supports flexible port placement, mimicking human arm movement, which aids in pre-operative planning for diverse surgical approaches. Its digital ecosystem, including Versius Connect and Versius Team, provides data-driven insights from past procedures to inform and optimize future surgical planning and resource allocation.
Intraoperative Guidance
The system features an integrated fluorescence visualization system, vLimeLite, offering real-time ICG imaging with multiple viewing modes (overlay, grayscale, green/cyan ICG color options) for enhanced tissue differentiation, vessel, blood flow, and biliary anatomy assessment. It provides 3D HD vision for a clear, magnified view of the surgical field, improving depth perception and visualization of anatomical structures.
3D Reconstruction Quality
Versius Plus offers advanced 3D HD vision, delivering high-definition visuals that enhance depth perception and improve the visualization of anatomical structures during surgery. This real-time 3D capability aids surgeons in navigating complex anatomies with greater clarity.
Robotic Surgery Integration
As a robotically assisted surgical device, Versius Plus is designed for precise control of endoscopic instruments. Its compact, portable, and modular design allows for independent robotic arms to be positioned flexibly around the patient and easily moved between operating rooms, integrating seamlessly into existing hospital infrastructure. The system utilizes fully wristed instruments compatible with 5mm ports.
Surgical Navigation Accuracy
The system provides surgeons with the dexterity and accuracy of small, fully wristed instruments, enabling precise surgical maneuvers. Powerful software maintains a virtual pivot point, ensuring consistent access and control throughout the procedure.
Post-Operative Monitoring
Versius Plus's digital ecosystem includes Versius Connect, a surgeon app providing a near-real-time logbook of procedures, and Versius Team, a live dashboard for surgical teams to track usage, case volume, and system efficiency. Versius Clinical Insights further combines telemetry data, clinical data, and surgical videos to offer insights into surgeon performance and patient outcomes, supporting continuous learning and program optimization.
Operating Room Workflow Integration
Designed to fit into virtually any operating room setup, Versius Plus integrates seamlessly into existing workflows. Its modular and portable nature allows for easy movement between departments and ORs, eliminating the need for dedicated robotic operating rooms and enabling hospitals to switch between robotic and non-robotic procedures efficiently. The open surgeon console promotes clear communication within the surgical team.
Physician Tip

Leverage the advanced 3D HD vision and vLimeLite fluorescence imaging for superior intraoperative visualization and enhanced decision-making, particularly for critical anatomical structures. Utilize the modular design to optimize patient positioning and port placement, adapting the setup to individual patient needs and diverse surgical procedures. Actively engage with the Versius Connect and Versius Team applications to review procedural data, track personal and team performance, and contribute to continuous learning and overall program optimization. The biomimetic wristed instruments are key for achieving precise maneuvers, especially in complex or confined anatomical spaces.

The Versius Plus system is engineered for seamless integration into existing operating room environments due to its compact, portable, and modular design, which negates the need for dedicated infrastructure or extensive remodeling. Its comprehensive digital ecosystem, encompassing Versius Connect, Versius Team, and Versius Clinical Insights, facilitates the integration of data-driven insights into hospital performance tracking, surgical training pathways, and continuous quality improvement initiatives. The system is compatible with standard 5mm laparoscopic ports and a full suite of endoscopic instruments, ensuring compatibility with established surgical practices.

Details

Category Surgical AI
Pricing Contact for pricing
DeploymentOn-premise (surgical robot system)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Versius Plus has received 510(k) clearance from the United States Food and Drug Administration (FDA) for adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, specifically for cholecystectomy. A 510(k) submission has also been filed for benign gynecologic indications.
Integrations
EHR Not specified
Specialties General Surgery, Obstetrics & Gynecology

What the Web Says

The Versius Plus, developed by CMR Surgical, is a robotic-assisted surgical system designed for minimally invasive procedures. It has gained significant traction globally, becoming the second most utilized soft-tissue surgical robot worldwide. The system received FDA 510(k) clearance for cholecystectomy in December 2025, with commercialization in the U.S. beginning in 2026. Physicians and healthcare IT professionals highlight its modularity, portability, and software-defined nature as key advantages.

Overall: Positive

Strengths

  • Modular and compact design allows for easy movement between operating rooms and departments, eliminating the need for a dedicated OR.
  • Software-defined features enable continuous updates and improvements based on user feedback without physical component changes.
  • Open console design facilitates communication between the surgeon and the surgical team, enhancing situational awareness and teaching opportunities.
  • Mimics human arm articulation and offers wristed instruments for precise control and greater surgical access.
  • Integrated fluorescence visualization technology (vLimeLite) provides real-time imaging for enhanced tissue differentiation and identification of anatomical structures.
  • Cost-effective compared to traditional surgical robots like the da Vinci system, making it more accessible to a wider range of healthcare providers.

Limitations

  • US regulatory indication is currently limited to cholecystectomy, with each new indication requiring additional FDA submissions.
  • The economic case for robotics in general surgery, where Versius Plus targets, is still being established.
  • Haptic feedback needs improvement.
  • The Ultrasonic Dissector, a significant enhancement, is not yet approved for sale in the United States.
  • Requires dedicated instruments, optical systems, and electrosurgical equipment, as well as structured training protocols and technical support for implementation.

Based on reviews from: Healthcare IT Today, Surgical Technologist, CMR Surgical, Robotics & Automation News, Cambridge Innovation Capital, PMC, VayoMed, Bis Research, MedTech Dive, MDPI, Medium, Markets Insider, IntuitionLabs

Last updated: 2026-08-26

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Versius Plus

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

GlobeNewswire
CMR Surgical and NVIDIA showcase future of intelligent surgery with Versius Plusu2122 at SRS 2026
CMR Surgical and NVIDIA demonstrated the potential of Versius Plus to use surgical data for predicting procedure outcomes at SRS 2026, leveraging NVIDIA Isaac for Healthcare's Medical Physics Simulation framework. This simulation aims to develop surgical robots that can anticipate, plan, and adapt, advancing CMR's vision of intelligent surgery for safer, more consistent care.
2026-07
Surgical Robotics Technology
CMR Surgical Announces 510(k) Clearance of its Versius Plus Robotic Surgical System
CMR Surgical's second-generation robotic platform, Versius Plus, received 510(k) clearance from the FDA for cholecystectomy procedures, with commercialization expected in 2026. The system features a flexible, modular design and a data-driven digital ecosystem, offering more choices for surgeons and hospitals.
2025-12
MD+DI
FDA Clears New Robotic Platform for Gallbladder Surgery
CMR Surgical received FDA 510(k) clearance for its Versius Plus surgical robotic platform for cholecystectomy procedures, with commercialization planned for 2026. The system boasts a flexible, modular design, a data-driven digital ecosystem, and an open console to enhance communication in the operating room.
2025-12
CMR Surgical
CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plusu2122 into Gynecology
CMR Surgical submitted a 510(k) premarket notification to the U.S. FDA for its Versius Plus Surgical Robotic System to expand its use into benign gynecology procedures, including total hysterectomy, oophorectomy, and salpingectomy. This follows its recent FDA clearance for cholecystectomy and builds on extensive global clinical experience in gynecology.
2026-04
Fierce Biotech
CMR Surgical kicks off Versius Plus robot's US commercial launch
Following FDA approval in December, CMR Surgical has launched its Versius Plus platform commercially in the U.S., coinciding with the milestone of 45,000 patients treated globally by Versius systems across various specialties. The company aims to partner with healthcare systems to expand robotic-assisted surgery access.
2026-03
Fierce Biotech
CMR Surgical grabs FDA clearance for upgraded Versius Plus robot
CMR Surgical received FDA 510(k) clearance for its Versius Plus system for minimally invasive gallbladder removal, an upgrade from its first-generation Versius. The new system incorporates near-infrared fluorescence imaging (vLimeLite) and can be equipped with an ultrasonic dissector.
2025-12
The Robot Report
CMR Surgical receives FDA clearance for Versius Plus surgical robot
CMR Surgical announced that its Versius Plus surgical robotic platform received 510(k) clearance from the U.S. FDA for cholecystectomy procedures. The system features a modular design, a data-driven digital ecosystem, and an open console to facilitate communication in the operating room.
2025-12
MDPI (International Journal of Medical Devices)
Robotic-Assisted Surgery for Colorectal Cancer Treatment in 2026: An Updated Narrative Review
The Versius Plus model incorporates indocyanine green (ICG) fluorescence imaging and employs four independent robotic arms with seven degrees of freedom, interchangeable among operative arms. Its modular architecture and independent robotic arms offer flexibility in operating room setup and port positioning for various specialties, including colorectal surgery.
2026-05

Videos

Product demos, reviews, and walkthroughs for Versius Plus.

View all on YouTube

Frequently Asked Questions

Versius Plus incorporates a 'digitally driven ecosystem' that provides real-time, data-driven insights through dedicated applications like Versius Connect and Versius Team. Versius Connect offers surgeons a near-real-time procedural logbook with case statistics and instrument usage timelines, while Versius Team provides live dashboards for tracking usage and system efficiency to optimize robotic programs. The system's computing architecture also supports AI modules for instrument tracking and surgical phase recognition, with future assessments for integrating advanced AI platforms like NVIDIA IGX Thor.
Versius Plus received 510(k) clearance from the FDA in December 2025 for cholecystectomy procedures. In the U.S., it is indicated for adult patients 22 years of age and older who are eligible for soft tissue minimal access surgery, specifically for gallbladder removal. The system's use is restricted to prescription and must be supervised by a qualified and trained physician.
Versius Plus is a next-generation, modular, and portable robotic system designed to offer greater flexibility in operating room setup and integration compared to fixed-tower systems like some da Vinci models. While it emphasizes data-driven insights and has AI modules for tracking and phase recognition, some competitors like Senhance offer haptic feedback, a feature not currently highlighted for Versius Plus. CMR Surgical states Versius is the second most utilized robotic surgical platform globally, after Intuitive Surgical.
The estimated capital cost for purchasing a Versius Plus system is approximately USD 0.75-1 million, which is generally presented as a more affordable alternative compared to the higher price points of some established systems like the da Vinci. Total ownership costs, however, will also depend on factors such as case volume, maintenance fees, and disposable instrument expenses. CMR Surgical offers both leasing models and outright purchase options.
In the U.S., Versius Plus is currently indicated for adult patients 22 years and older for soft tissue minimal access surgery, specifically cholecystectomy. The long-term safety and effectiveness of the device for use with or treatment of cancer has not yet been established. Physicians should always refer to the product labeling for a complete list of warnings, precautions, and contraindications.
The Versius Plus digital ecosystem, through applications like Versius Connect and Versius Team, collects robotic telemetry data, procedural case videos, and clinical context information. While the system is designed to provide actionable insights and support continuous learning, specific details on data encryption, anonymization, and compliance with patient privacy regulations (e.g., HIPAA) would typically be outlined in the system's security protocols and user agreements. These platforms are intended to inform better decision-making and improve patient outcomes.
CMR Surgical is actively exploring and assessing the integration of more powerful AI platforms, such as NVIDIA IGX Thor, into the Versius system. This suggests a future direction towards enhancing its existing AI modules for instrument tracking and surgical phase recognition with more advanced computational capabilities. The company aims to continually deliver new features and performance improvements through software updates within its digitally driven ecosystem.

Related Tools

IntelliLogic Ai
IntelliLogic AI
Surgical AI
IntelliLogic AI is an AI-powered operating system for medical device distribution, unifying surgical cases, field inventory, chargesheets, commissions, and analytics into a single, HIPAA-ready platform.
Tailored to team size, module mix, and integrations.
XACT ACE Robotic
XACT Robotics
Radiology & Imaging AI
The XACT ACE® Robotic System is the world's first and only comprehensive robotic system that combines image-guided planning and real-time monitoring with precise robotic insertion and S-Drive™ technology to deliver various instruments to a desired target in the body with unparalleled accuracy, unmatched consistency, and unlimited efficiency.
Proximie
Proximie Inc.
Clinical Decision Support & Reference
Proximie connects everything in the OR—people, data, and devices—to improve surgical throughput and quality through real-time, AI-powered insight and orchestration.
Proprio Paradigm
Proprio
Clinical Decision Support & Reference
Proprio Paradigm is an FDA-cleared, AI-powered surgical navigation platform that uses advanced sensors, computer vision, and AI to create real-time 3D models of anatomy, improving precision and streamlining workflows.
Contact sales
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Paid
OrthoPlan
OrthoPlan
Clinical Decision Support & Reference
OrthoPlan is an AI-enhanced digital templating software for orthopedic surgery that streamlines surgical planning and offers automated bone segmentation and implant positioning.

See all Surgical AI tools →

Suggest an Edit → | Last Verified: 2026-05-27 | First Added: 2026-05-27
AI Tool Finder
AI-powered search. Results may not be comprehensive.